Labcorp Holdings Inc. declared a quarterly cash dividend of $0.72 per share, payable on December 11, 2026. The company paid out over $750 million tests in 2025, and supported 85% of new FDA approved drugs.
Labcorp Holdings Inc. declared a quarterly cash dividend of $0.72 per share, payable on December 11, 2026. The company paid out over $750 million tests in 2025, and supported 85% of new FDA approved drugs.